Titan Energy Appoints Christopher Walker as Chief Operating Officer
Mar 01, 2018 21:30 pm UTC| Business
FORT WORTH, Texas, March 01, 2018 -- Titan Energy, LLC (OTCQX:TTEN) and its subsidiaries (“Titan”) today announced the appointment of Christopher Walker as Chief Operating Officer of Titan, which will take effect as of...
Nasdaq Files Patent Infringement Lawsuit to Protect Intellectual Property
Mar 01, 2018 21:30 pm UTC| Business
NEW YORK, March 01, 2018 -- Nasdaq (Nasdaq:NDAQ) filed a patent infringement lawsuit in the United States District Court for the District of New Jersey today, aiming to protect Nasdaq’s electronic trading technology...
Zafgen to Host Conference Call to Discuss Fourth Quarter and Full Year 2017 Financial Results
Mar 01, 2018 21:30 pm UTC| Business
BOSTON, March 01, 2018 -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients affected by a range...
KMG Declares Quarterly Dividend
Mar 01, 2018 21:30 pm UTC| Business
FORT WORTH, Texas, March 01, 2018 -- KMG (NYSE:KMG), a global provider of specialty chemicals and performance materials, today announced that its Board of Directors has declared a quarterly cash dividend of $0.03 per...
Unitil Announces Leadership Change Effective April 25, 2018
Mar 01, 2018 21:30 pm UTC| Business
HAMPTON, N.H., March 01, 2018 -- Unitil Corporation (“Unitil” or the “Company”) (NYSE:UTL) (www.unitil.com) today announced that Robert G. Schoenberger, 67, will retire as Chairman of the Board, President and Chief...
Mar 01, 2018 21:30 pm UTC| Business
LOS ANGELES, March 01, 2018 -- B. Riley Financial, Inc. (NASDAQ:RILY), a diversified financial services company, will hold a conference call on Wednesday, March 7 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to...
MyoKardia to Report Fourth Quarter and Full Year 2017 Financial Results on Thursday, March 8, 2018
Mar 01, 2018 21:30 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., March 01, 2018 -- MyoKardia, Inc. (Nasdaq:MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases,...